Insider Selling: Heartflow (NASDAQ:HTFL) Insider Sells $422,950.00 in Stock

Heartflow logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Heartflow insider Campbell Rogers sold 16,918 shares for $422,950 at $25 per share, cutting his position by 50%. The sale was made under a pre-arranged Rule 10b5-1 trading plan.
  • Heartflow shares fell 2.7% to $44.63 in Thursday trading. The company’s latest quarterly loss per share of $0.03 was narrower than analysts’ expected loss of $0.18.
  • Analysts’ consensus rating is “Moderate Buy,” with an average price target of $60.12.
  • MarketBeat previews top five stocks to own in December.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) insider Campbell Rogers sold 16,918 shares of the stock in a transaction on Thursday, March 19th. The shares were sold at an average price of $25.00, for a total transaction of $422,950.00. Following the transaction, the insider directly owned 16,918 shares in the company, valued at approximately $422,950. This represents a 50.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Campbell Rogers also recently made the following trade(s):

  • On Thursday, October 22nd, Campbell Rogers sold 12,157 shares of Heartflow stock. The shares were sold at an average price of $55.01, for a total transaction of $668,756.57.
  • On Friday, September 18th, Campbell Rogers sold 12,156 shares of Heartflow stock. The shares were sold at an average price of $50.15, for a total transaction of $609,623.40.
  • On Tuesday, November 17th, Campbell Rogers sold 12,157 shares of Heartflow stock. The shares were sold at an average price of $46.39, for a total transaction of $563,963.23.
  • On Tuesday, November 17th, Campbell Rogers sold 24,188 shares of Heartflow stock. The stock was sold at an average price of $46.39, for a total value of $1,122,081.32.
  • On Thursday, October 22nd, Campbell Rogers sold 23,933 shares of Heartflow stock. The shares were sold at an average price of $55.01, for a total transaction of $1,316,554.33.
  • On Friday, September 18th, Campbell Rogers sold 19,682 shares of Heartflow stock. The stock was sold at an average price of $50.15, for a total transaction of $987,052.30.

Heartflow Trading Down 2.7%

Shares of NASDAQ:HTFL traded down $1.26 during midday trading on Thursday, reaching $44.63. 1,279,655 shares of the company were exchanged, compared to its average volume of 1,615,683. The stock has a market cap of $3.92 billion, a PE ratio of -48.51 and a beta of 2.50. The business's fifty day moving average is $51.84 and its two-hundred day moving average is $35.47. Heartflow, Inc. has a one year low of $20.13 and a one year high of $60.65.

Heartflow (NASDAQ:HTFL - Get Free Report) last announced its quarterly earnings results on Thursday, November 12th. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.18) by $0.15. Heartflow had a negative net margin of 33.11% and a negative return on equity of 20.53%. The business had revenue of $72.86 million for the quarter. During the same quarter in the previous year, the firm earned ($0.27) EPS. As a group, sell-side analysts expect that Heartflow, Inc. will post -0.75 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on HTFL shares. JPMorgan Chase & Co. raised their price target on Heartflow from $35.00 to $45.00 and gave the company an "overweight" rating in a report on Friday, August 14th. Morgan Stanley boosted their price target on shares of Heartflow from $35.00 to $40.00 and gave the stock an "equal weight" rating in a research report on Friday, August 14th. Benchmark reaffirmed a "buy" rating on shares of Heartflow in a research note on Friday, August 14th. UBS Group assumed coverage on shares of Heartflow in a report on Wednesday, September 9th. They issued a "neutral" rating and a $55.00 target price on the stock. Finally, Wells Fargo & Company increased their price target on shares of Heartflow from $39.00 to $70.00 and gave the company an "overweight" rating in a report on Friday, November 13th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, Heartflow has an average rating of "Moderate Buy" and a consensus target price of $60.12.

Get Our Latest Report on Heartflow

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of HTFL. XXEC Inc. purchased a new stake in shares of Heartflow in the second quarter valued at $2,524,764,000. BlackRock Inc. purchased a new position in shares of Heartflow during the 2nd quarter worth about $152,502,000. Bamco Inc. NY bought a new position in Heartflow during the 2nd quarter valued at about $94,625,000. Jupiter Topco LLC purchased a new stake in Heartflow in the 2nd quarter worth about $70,983,000. Finally, Janus Henderson Group PLC raised its position in Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company's stock worth $53,063,000 after purchasing an additional 1,315,416 shares during the period.

Heartflow Company Profile

(Get Free Report)

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient's coronary arteries and provide information that can support diagnosis and treatment planning. The company's offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.

Further Reading

Insider Buying and Selling by Quarter for Heartflow (NASDAQ:HTFL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Heartflow Right Now?

Before you consider Heartflow, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Heartflow wasn't on the list.

While Heartflow currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines